Pharma

A pivotal advancement in cancer treatment unfolds as ENHERTU secures its approval in China, offering a specialized option for patients battling hormone receptor-positive and...

In recent years, Alzheimer's research has been shifting paradigms, moving beyond amyloid-centric approaches to explore a wider array of molecular and mechanistic targets. Insights...

Catalonia's BioRegion experienced an extraordinary year, marked by substantial investment influxes, scientific breakthroughs, and transformative entrepreneurial initiatives that cemented its role as a European...

UCB hosted its third Epilepsy Digital Roundtable on December 3, 2025, marking a significant commitment towards enhancing patient outcomes through digital health initiatives. The...

In recent years, an intriguing link between viral infections and cancer progression has captured scientific attention. Among these infections, Human Papillomavirus (HPV) emerges as...

Blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare and aggressive form of blood cancer that presents characteristics of both leukemia and lymphoma, has long...

Set against an evolving landscape of therapeutic innovation, Jazz Pharmaceuticals has slated significant investor events for early January 2026, offering stakeholders an opportunity to...

In the realm of rare diseases, the anticipation of breakthrough treatments often sparks hope among affected individuals and medical communities. The FALKON trial, a...

The European Medicines Agency (EMA) recently announced significant updates on drug labelling exemptions across multiple pharmaceutical products. These exemptions, granted under Article 63 of...

The treatment landscape for adult patients battling systemic lupus erythematosus (SLE) takes a significant step forward with the introduction of Saphnelo. This innovative medication...

Addressing the opioid epidemic among persons with experience of homelessness (PEH) presents unique challenges, especially within the framework of the Department of Veterans Affairs...

New Zealand’s Pharmac has released its December update on the prioritization of funding for medicines, vaccines, and related products, underscoring its dedication to transparency....

Governments and biotech innovators find themselves at a crucial junction as they navigate the evolving pharmaceutical ecosystem in Europe. With the introduction of new...

A recent study introduces a paradigm shift in the fight against human papillomavirus (HPV) in South Korea by advocating for a gender-neutral vaccination approach....

In a bid to find effective treatments for adult-onset Still's disease (AOSD) that no longer respond to standard glucocorticoid therapy, researchers embarked on an...